Anti-diabetic and anti-lipidepmic effect of Albizia lebbeck seeds against HepG2 cells.

Albizia lebbeck has been a medicinally important plant for its pharmacological potential. This study aims to determine the in vitro antioxidant, anti-diabetic and anti-lipidemic potential of A. lebbeck seeds. The seed extracts were prepared in petroleum ether, chloroform and methanol. Crude methanolic extract (ME ext) was subjected further to sequential fractionation in increasing polarity based solvents. Extracts and fractions were analyzed for their antioxidant, anti-diabetic and anti-lipidemic potentials using hepatic cell line, HepG2. Results showed that crude extracts of A. lebbeck seeds specifically, ME ext are rich in polyphenols and flavonoids. ME ext has also shown highly significant antioxidant and alpha-amylase inhibition potential compared to petroleum ether and chloroform extracts. In vitro assays using different fractions of methanolic extract further highlighted the ethyl acetate and chloroform fractions exhibiting significant antioxidant and anti-diabetic potentials. Alpha-amylase inhibition coupled with enhanced glucose uptake of cells treated with ME ext and ethyl acetate fraction emphasized on significant anti-diabetic potential of the plant. Expression alteration of genes and reduced level of cholesterol suggested the lipid synthesis mediated anti-diabetic activity of the plant. It is therefore, concluded that A. lebbeck seed has significant antioxidant, anti-diabetic and anti-lipidemic potentials.